SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (8012)3/13/2003 1:44:19 AM
From: Tim O.  Read Replies (1) of 52153
 
Peter,

What's your opinion on CEGE? It's chart looks really bad with no real bottom in sight, but it is near book value. CEGE has a lot of cash and no liquidity issues, yet it's been hit a lot harder than the BTK index.

In particular, I'm interested in your thoughts on it's biotech research prospects (since I'm not smart enough to study this).

Tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext